Increasing evidence suggests that epilepsy is the result of synaptic reorganization and pathological excitatory loop formation in the central nervous system; however, the mechanisms that regulate this process are not well understood. We proposed that microRNA-132 (miR-132) and p250GAP might play important roles in this process by activating the downstream Rho GTPase family. We tested this hypothesis using a magnesium-free medium-induced epileptic model of cultured hippocampal neurons. We investigated whether miR-132 regulates GTPase activity through p250GAP and found that Cdc42 was significantly activated in our experimental model. Silencing miR-132 inhibited the electrical excitability level of cultured epileptic neurons, whereas silencing p250GAP had an opposite effect. In addition, we verified the effect of miR-132in vivoand found that silencing miR-132 inhibited the aberrant formation of dendritic spines and chronic spontaneous seizure in a lithium-pilocarpine-induced epileptic mouse model. Finally, we confirmed that silencing miR-132 has a neuroprotective effect on cultured epileptic neurons; however, this effect did not occur through the p250GAP pathway. Generally, silencing miR-132 may suppress spontaneous seizure activity through the miR-132/p250GAP/Cdc42 pathway by regulating the morphology and electrophysiology of dendritic spines; therefore, miR-132 may serve as a potential target for the development of antiepileptic drugs.
Whether very early mobilization (VEM) improves outcomes in stroke patients and reduces immobilization-related complications (IRCs) is currently unknown. The objective of this systematic review and meta-analysis was to evaluate the efficacy and safety of VEM in acute stroke patients following admission. Medline, Embase, and Cochrane Central Register of Controlled Trials databases were searched for randomized controlled trials (RCTs) that examined the efficacy or safety of VEM in patients with acute stroke. VEM was defined as out of bed activity commencing within 24 or 48 hours after the onset of stroke. A total of 9 RCTs with 2,803 participants were included. Upon analysis, VEM was not associated with favorable functional outcomes (modified Ranking Scale: 0–2) at 3 months [relative risk (RR): 0.96; 95% confidence interval (CI): 0.86–1.06]; VEM did not reduce the risk of IRCs during follow up. With respect to safety outcomes, VEM was not associated with a higher risk of death (RR: 1.04; 95% CI: 0.52–2.09) and did not increase the risk of neurological deterioration or incidence of falls with injury. In conclusion, pooled data from RCTs concluded that VEM is not associated with beneficial effects when carried out in patients 24 or 48 hours after the onset of a stroke.
Thrombolytic therapy rate for acute ischemic stroke remains low, and improving public awareness of thrombolytic therapy may be helpful to reduce delay and increase chances of thrombolytic therapy. Our purpose was to survey the level of knowledge about thrombolytic therapy for acute ischemic stroke among community residents in Yuzhong district, Chongqing, China. In 2011, a population-based face-to-face interview survey was conducted in Yuzhong district, Chongqing. A total of 1500 potential participants aged ≥18 years old were selected using a multi-stage sampling method. A total of 1101 participants completed the survey. Only 23.3% (95% CI = 20.8 to 25.8) were aware of thrombolytic therapy for acute ischemic stroke, of whom 59.9% (95% CI = 53.9 to 65.9) knew the time window. Awareness of thrombolytic therapy was higher among young people, those with higher levels of education and household income, those with health insurance, and those who knew all 5 stroke warning signs, while awareness of the time window was higher among those aged 75 years or older. Multivariate logistic regression analysis showed that awareness of thrombolytic therapy was independently associated with age, education level, health insurance and knowledge of stroke warning signs (P<0.05). In this population-based survey the community residents have poor awareness of thrombolytic therapy for acute ischemic stroke.
8 December 2023 in International Journal of Energy Research
Perchlorate (ClO4-) in drinking water is one of the most serious issues relating to drinking water contamination. This work reports both the experimental and computational investigation of wastewater perchlorate adsorption on surfactant-modified activated carbon cloth (ACC) in order to design an efficient water treatment system. Three different types of cationic surfactants including tetramethylammonium (TMA), benzyltrimethylammonium (BTMA), and dodecyltrimethylammonium (DDTMA) were employed in this study, and the ClO4- adsorption capacity of various adsorbents was determined in batch experiments for 24 hours. Among all, DDTMA-ACC exhibits the highest ClO4- adsorption capacity (4.5 times that of pristine ACC), the highest monolayer coverage capacity () value (0.59 mmol/g), an equilibrium adsorption constant () value (35.90 L/mmol), and the lowest value (-26.0 KJ/mol), revealing that ClO4- has a stronger affinity for ACC functionalized by DDTMA than ACC functionalized by other surfactants. Molecular dynamics (MD) simulations were also conducted to illustrate the interactions among ClO4-, surfactants, and a model graphite surface underwater environment. The relative number density profiles and cumulative number studies demonstrate that TMA/BTMA tends to form single-layered packing near the graphite surface, while DDTMA prefers to pack in a multilayered fashion. The dense packing behavior of DDTMA on the graphite surface can enhance the ClO4- adsorption, showing good agreement with experimental results.